Onkologie. 2015:9(5):214-217

Complex therapy of brain glioma

Pavel Fadrus1, Pavel Šlampa2, Radek Lakomý3, Martin Smrčka1
1 Neurochirurgická klinika, FN Brno &ndash, Bohunice a LF MU, Brno
2 Klinika radiační onkologie, Masarykův onkologický ústav, Brno
3 Klinika komplexní onkologické péče, Masarykův onkologický ústav, Brno

Glioma is a common type of primary brain intraaxial tumors. This is a broad group of tumors that differ in their typical localization,

age predisposition, morphology, degree of malignancy and the tendency to progression. On the basis of the WHO classification with

grading system are divided into two basic groups: glioma low grade malignancy (low grade glioma – LGG) and glioma high grade of

malignancy (high grade glioma – HGG). These two groups in between vary considerably in their biological characteristics and thus the

overall prognosis of the patient. Among the basic capabilities of their therapies include surgical resection followed by radiation therapy

and chemotherapy. In the article are analyzed the possibilities and limitations of these various modalities of treatment for LGG and HGG.

Keywords: brain glioma, surgical resection, radiation therapy, chemotherapy

Published: December 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fadrus P, Šlampa P, Lakomý R, Smrčka M. Complex therapy of brain glioma. Onkologie. 2015;9(5):214-217.
Download citation

References

  1. Wen PY, Kesari S. Malignant gliomas in adults. N. Engl. J. Med. 2008; 359: 492-507. Go to original source... Go to PubMed...
  2. Laws ER, et al. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J. Neurosurg. 2003; 99: 467-473. Go to original source... Go to PubMed...
  3. Henson JW, Gaviani P, Gonzalez RG. MRI in treatment of adult gliomas. Lancet Oncol 2005; 6: 167-175. Go to original source... Go to PubMed...
  4. Chang EF, Smith JS, Chang SM, et al. Preoperative prognostic classification system for hemispheric low-grade gliomas in adults. J Neurosurg 2008; 109: 817-824. Go to original source... Go to PubMed...
  5. Stupp R, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5 year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009; 10: 459-466. Go to original source...
  6. Gore JC, Manning HC, Quarles CC, Waddell KW, Yankeelov TE. Magnetic resonance in the era of molecular imaging of cancer. Magn. Reson. Imaging 2011; 29: 587-600. Go to original source... Go to PubMed...
  7. De Witt Hamer PC, Robles SG, Zwinderman AH, Duffau H, Berger MS. Impact of intraoperative stimulation brain mapping on glioma surgery outcome: a meta-analysis. J. Clin. Oncol. 2012; 30: 2559-2565. Go to original source... Go to PubMed...
  8. Smith JS, Chang EF, Lamborn KR, et al. Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 2008; 26: 1338-1345. Go to original source...
  9. Lacroix M, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J. Neurosurg. 2001; 95: 190-198. Go to original source...
  10. Vuorinen V, Hinkka S, Farkkila M, Jaaskelainen, J. Debulking or biopsy of malignant glioma in elderly people-a randomised study. Acta Neurochir. 2003; 145: 5-10. Go to original source... Go to PubMed...
  11. Tatter SB. Recurrent malignant glioma in adults. Curr. Treat. Options Oncol.2002; 23: 509-524. Go to original source...
  12. Šlampa P, a kol. Radiační onkologie v praxi. Čtvrté aktualizované vydání. Masarykův onkologický ústav, Brno, 2014: 221-250.
  13. Wick W, Platten M, Meisner C, et al. Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol. 2012; 13(7): 707-715. Go to original source...
  14. Hoskin, P. Radiotherapy in practice: External beam therapy. Reprinted 2009: Oxford, p. 478.
  15. NCCN Clinical Practice Guidelines in Oncology, version 1.2015.
  16. Šlampa P, Kazda T. Konzervativní postupy v léčbě gliomů. Postgraduální medicína 2013; 15(3): 277-281.
  17. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 2005; 352(10): 987-996. Go to original source... Go to PubMed...
  18. Wick W, Hartmann C, Engel C, et al. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. J Clin Oncol 2009; 27: 5874-5880. Go to original source... Go to PubMed...
  19. van den Bent MJ, Brandes AA, Taphoorn MJ, et al. Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC Brain Tumor Group study 26951. J Clin Oncol. 2013; 31(3): 344-350. Go to original source... Go to PubMed...
  20. Cairncross G, Wang M, Shaw E, et al. Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol. 2013; 31(3): 337-343. Go to original source... Go to PubMed...




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.